Idera Pharmaceuticals is looking for recruits to enroll in s Phase II study of IMO-8400 in adult dermatomyositis patients. In total they expect to enroll 48 patients across 20 sites in the US and the UK.
One of the recruiting sites is in Phoenix, Arizona under the direction of Dr. Todd Levine. Dr. Levine has spoken to our support group a couple of years ago and has been on the TMA Medical Advisory Board. He has been to the forefront for a lot of clinical studies into drugs treating myositis, including Rituxan and Acthar.
More information can be found at the clinical trials website. Click here
Also the TMA website has information about the trial. Click here
In addition I have received information packs from Idera about the clinical trials. If interested in these packs please let me know.